This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Uniwersytet Jagielloński. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Eliza Turlej: Innovator in Aromatic Sulphonamides Derivatives
Introduction
Eliza Turlej is a prominent inventor based in Wrocław, Poland. She has made significant contributions to the field of medicinal chemistry, particularly through her innovative work on aromatic sulphonamides derivatives. Her research focuses on developing compounds that can modulate the activity of protein disulfide isomerase (PDI), which has implications for various therapeutic applications.
Latest Patents
Eliza Turlej holds a patent for "Aromatic sulphonamides derivatives that inhibit PDI A3, their synthesis and use." This invention relates to a new group of aromatic sulphonamides derivatives of formula (I) and their synthesis and use for modulation of the activity of PDI. More specifically, the invention provides small molecule inhibitors of PDI A3 that display antiplatelet, antithrombotic, and anticancer activities. She has 1 patent to her name, showcasing her innovative approach to drug development.
Career Highlights
Eliza is affiliated with Jagiellonian University, where she conducts her research and contributes to the academic community. Her work has garnered attention for its potential impact on treating various diseases, including cancer and thrombotic disorders.
Collaborations
Throughout her career, Eliza has collaborated with notable colleagues such as Stefan Chlopicki and Ilona Domraceva. These partnerships have enriched her research and expanded the scope of her innovative projects.
Conclusion
Eliza Turlej is a trailblazer in the field of medicinal chemistry, with her work on aromatic sulphonamides derivatives paving the way for new therapeutic options. Her contributions to science and collaboration with esteemed colleagues highlight her commitment to advancing medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile